HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
about
Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysisDesigning ARVs Patent Pool Up to Trade & Policy Evolutionary DynamicsFactors influencing global antiretroviral procurement prices.Impending flop for brand antiretrovirals in the emerging markets?Sequence diversity and novelty of natural assemblages of picoeukaryotes from the Indian Ocean.Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets.Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.Recent developments in hiv treatment and their dissemination in poor countriesHIV/AIDS Clinical Manifestations and their Implication for Patient Clinical Staging in Resource Limited Settings in Tanzania.The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabweEffectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.The make or buy debate: considering the limitations of domestic production in Tanzania.HIV treatment optimism and its predictors among young adults in southern MalawiGlobal strategies to reduce the price of antiretroviral medicines: evidence from transactional databasesAffordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioningTherapeutic drug monitoring in highly active antiretroviral therapy.Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community.Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias' in access to imported medicines in Tanzania and its policy implications.Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
P2860
Q27316535-BA597B84-64ED-4D30-84D2-454BB392DC83Q30397036-4F06E31E-F38D-4F62-979B-924284295F88Q30892581-14B53EF6-DF4A-4290-ABAC-D75DB0CE8C80Q33377043-B367508F-318D-4B89-B742-87168E20006EQ33633022-7455D3DD-B9E7-49E9-9B83-A6466B1A3DCFQ33907223-A622B5E1-7343-470B-B568-393389A8FF8DQ33952538-8E8730BC-19D3-4BCB-A1EF-7F3925FB3726Q34400513-9FE0D120-25E5-4FED-9CCE-3025F96166AAQ35012921-3E3EC687-5E08-461A-85FE-6AB93A65039FQ35855545-8806BA9C-00BE-4FB4-8F9F-06D0B9C4EACAQ35883654-C10DAE05-617E-4995-8BE7-A9F1EE0E5DDFQ36146319-DEB31A5D-ADE0-42EB-9BC9-A92344E0099AQ36704086-A4FCE87F-9128-4EB5-8735-5D8C5888E673Q37246018-F785D4BC-285F-4F16-A259-B1E1C5A4F57AQ37355309-A08DB97E-6D28-49F7-B2FE-989A7DA4E0A1Q37720765-C7091653-EFC4-482D-9FFB-ED58E5F4C92CQ38957818-0626B9B6-E163-4264-A2B8-90855D66FFE3Q39635766-0FC43380-D0CA-40CB-86C2-7E46D2691F01Q42234067-A4E728C6-FA93-4A02-824C-F3F2B70F85D9
P2860
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@ast
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@en
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@nl
type
label
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@ast
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@en
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@nl
prefLabel
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@ast
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@en
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@nl
P2860
P1433
P1476
HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
@en
P2093
Colleen V Chien
P2860
P356
10.1371/JOURNAL.PONE.0000278
P407
P577
2007-03-14T00:00:00Z